Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infections. The optimal scenario for implementing PrEP where most infections are averted at the lowest cost is unknown. We determined the impact of different PrEP strategies on averting new infections, prevalence, drug resistance and cost-effectiveness in Macha, a rural setting in Zambia. Methods: A deterministic mathematical model of HIV transmission was constructed using data from the Macha epidemic (antenatal prevalence 7.7%). Antiretroviral therapy is started at CD4,350 cells/mm3. We compared the number of infections averted, cost-effectiveness, and potential emergence of drug resistance of two ends of the prioritization spectrum: p...
Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, du...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
Thesis (Ph.D.)--University of Washington, 2022Daily oral tenofovir disoproxil fumarate and emtricita...
BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
<div><p>Background</p><p>Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectivel...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: Earlier antiretroviral therapy initiation and pre-exposure prophylaxis (PrEP) prevent HI...
Item does not contain fulltextBACKGROUND: Earlier antiretroviral therapy initiation and pre-exposure...
Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, du...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
Thesis (Ph.D.)--University of Washington, 2022Daily oral tenofovir disoproxil fumarate and emtricita...
BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
<div><p>Background</p><p>Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectivel...
Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infect...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: Earlier antiretroviral therapy initiation and pre-exposure prophylaxis (PrEP) prevent HI...
Item does not contain fulltextBACKGROUND: Earlier antiretroviral therapy initiation and pre-exposure...
Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, du...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
Thesis (Ph.D.)--University of Washington, 2022Daily oral tenofovir disoproxil fumarate and emtricita...